This page includes links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024.

(HealthDay News) — Health care spending in the United States reached $4.9 trillion ($14,570 per person) in 2023, according to data published in Health Affairs. Researchers found that US health care ...

Many patients with multiple myeloma experience persistent pain and use opioids to manage that pain even after they achieve remission, a survey suggests.

The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy to treat unresectable or metastatic, HER2-, PD-L1+ gastric or GEJ adenocarcinoma.

Bicistronic CAR T-cell therapy can produce durable complete responses in pediatric patients with relapsed or refractory B-ALL, data suggest.

(HealthDay News) — The mean body mass index (BMI) and prevalence of obesity declined in the United States in 2023, according to research published in JAMA Health Forum.

Both dose levels of modakafusp alfa “resulted in good response rates with similar safety profiles,” according to researchers.

The risk of melanoma-related death is greater for patients with primary tumors that are 0.8-1.0 mm thick than for patients with thinner tumors, data suggest. President-elect Donald Trump is ...